TY - JOUR
T1 - An intron 4 gene polymorphism in endothelial cell nitric oxide synthase might modulate volume-dependent hypertension in patients on hemodialysis
AU - Yokoyama, Keitaro
AU - Tsukada, Toshihiko
AU - Nakayama, Masaaki
AU - Hara, Sigeko
AU - Yamada, Akira
AU - Kawaguchi, Yoshindo
AU - Hosoya, Tatsuo
PY - 2000
Y1 - 2000
N2 - Nitric oxide (NO) has some relevance to the pathophysiology of hypertension. We examined the distribution of endothelial nitric oxide synthase (ecNOS4) gene polymorphism in patients with essential hypertension (n = 107) in comparison with healthy subjects (n = 362), and then studied the possibility that ecNOS4 gene polymorphism affects changes in blood pressure (BP) due to water load in hemodialysis patients. Though the NO metabolite (NOx) level in subjects with the a allele (31.2 ± 1.76 μmol/ l) was significantly lower than in those without the a allele (35.6 ± 0.90 μmol/l) (p = 0.0263), we found no association between this gene polymorphism and essential hypertension. However, there still remains the possibility that the NO response to elevation of BP might be suppressed in patients with hypertension. In order to examine the association between ecNOS4 gene polymorphism and volume-dependent hypertension, 181 hemodialysis patients with complete anuria were recruited. Depending on the increase in mean BP (mm Hg) divided by percent increase in body weight (ΔBP/ΔBW), patients were divided into high responders (High-R: ΔBP/ΔBW>2.0 mm Hg; n = 90) and low responders (Low-R: ΔBP/ΔBW <2.0 mm Hg; n = 91). In the High-R group, the frequencies of a/a, b/a and b/b genotypes were 1.1, 32.1 and 66.8%, respectively, and in the Low-R group, these frequencies were 1.1, 9.4 and 89.5%, respectively. The relative risk for those in the High-R group conferred by the ecNOS4 a allele (b/a + a/a) was 3.64 (95% confidence intervals: 1.60-8.24, p = 0.0089). This study did not show a strong involvement of ecNOS4 gene polymorphism, at least in the basal NO production in patients with essential hypertension, however, it indicated that ecNOS4 gene polymorphism might modulate changes in BP due to water load in patients on hemodialysis, thus indicating that these polymorphisms may be involved in the pathophysiology of volume-dependent hypertension. Copyright (C) 2000 S. Karger AG, Basel.
AB - Nitric oxide (NO) has some relevance to the pathophysiology of hypertension. We examined the distribution of endothelial nitric oxide synthase (ecNOS4) gene polymorphism in patients with essential hypertension (n = 107) in comparison with healthy subjects (n = 362), and then studied the possibility that ecNOS4 gene polymorphism affects changes in blood pressure (BP) due to water load in hemodialysis patients. Though the NO metabolite (NOx) level in subjects with the a allele (31.2 ± 1.76 μmol/ l) was significantly lower than in those without the a allele (35.6 ± 0.90 μmol/l) (p = 0.0263), we found no association between this gene polymorphism and essential hypertension. However, there still remains the possibility that the NO response to elevation of BP might be suppressed in patients with hypertension. In order to examine the association between ecNOS4 gene polymorphism and volume-dependent hypertension, 181 hemodialysis patients with complete anuria were recruited. Depending on the increase in mean BP (mm Hg) divided by percent increase in body weight (ΔBP/ΔBW), patients were divided into high responders (High-R: ΔBP/ΔBW>2.0 mm Hg; n = 90) and low responders (Low-R: ΔBP/ΔBW <2.0 mm Hg; n = 91). In the High-R group, the frequencies of a/a, b/a and b/b genotypes were 1.1, 32.1 and 66.8%, respectively, and in the Low-R group, these frequencies were 1.1, 9.4 and 89.5%, respectively. The relative risk for those in the High-R group conferred by the ecNOS4 a allele (b/a + a/a) was 3.64 (95% confidence intervals: 1.60-8.24, p = 0.0089). This study did not show a strong involvement of ecNOS4 gene polymorphism, at least in the basal NO production in patients with essential hypertension, however, it indicated that ecNOS4 gene polymorphism might modulate changes in BP due to water load in patients on hemodialysis, thus indicating that these polymorphisms may be involved in the pathophysiology of volume-dependent hypertension. Copyright (C) 2000 S. Karger AG, Basel.
KW - Blood pressure
KW - DNA polymorphism
KW - Endothelial nitric oxide synthase
KW - Hemodialysis
KW - Plasma nitrite and nitrate
UR - http://www.scopus.com/inward/record.url?scp=0033938307&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033938307&partnerID=8YFLogxK
U2 - 10.1159/000045666
DO - 10.1159/000045666
M3 - Article
C2 - 10867538
AN - SCOPUS:0033938307
VL - 85
SP - 232
EP - 237
JO - Nephron
JF - Nephron
SN - 0028-2766
IS - 3
ER -